X

Trial Profile

A multicentre randomised trial of single dose radiotherapy compared to ibandronate for localised metastatic bone pain.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ibandronic acid (Primary)
Indications Bone metastases; Prostate cancer
Focus Therapeutic Use
Acronyms RIB

Most Recent Events

27 Sep 2011 Results presented at the 2011 European Multidisciplinary Cancer Congress.
10 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
25 Mar 2010 United Kingdom Clinical Research Network reports acrual to date changed from 117% to 118%.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com